Skip to main content
. 2026 Jun 20;16(6):331. doi: 10.3390/jpm16060331
GHRH Growth Hormone-Releasing Hormone
AML Acute Myeloid Leukemia
GHRH-R Growth Hormone-Releasing Hormone Receptor
APL Acute Promyelocytic Leukemia
ATRA All-Trans-Retinoic Acid
ATO Arsenic Trioxide
IGF-I Insulin-Like Growth Factor 1
SV Splice Variant
pGHRH-R Pituitary Growth Hormone-Releasing Hormone
RAA ATRA/ATO Resistance
ELN European LeukemiaNet
NCCN National Comprehensive Cancer Network
FLT3 Fms-Like Tyrosine Kinase 3
FLT3-L Fms-Like Tyrosine Kinase 3-Ligand
FLT3-ITD Fms-Like Tyrosine Kinase 3 In-Frame Internal Tandem Duplication
FLT3-TKD Fms-Like Tyrosine Kinase 3 Tyrosine Kinase Domain
R/R Relapsed or Refractory
OS Overall Survival
TFA Trifluoroacetic Acid
MIA-602 (Ac) Acetate Salt Form of MIA-602
HMA Hypomethylating Agent
LoDAC Low-Dose Cytarabine
PML Promyelocytic Leukemia
HSCT Hematopoietic Stem Cell Transplant
PKA Protein Kinase A
GPCR G Protein-Coupled Receptor
AKT Protein Kinase B
PI3K Phosphoinositide 3-Kinase
cAMP Cyclic Adenosine Monophosphate
IDH 1/2 Isocitrate Dehydrogenase 1/2
CBF Core Binding Factor
NPM1 Nucleophosmin 1
KMT2A Lysine Methyltransferase 2A